Holen Sie sich die Stockscreener-App
3.825
2.42%
-0.095
Handel nachbörslich:
3.83
0.005
+0.13%
Climb Bio Inc Aktie (CLYM) Neueste Nachrichten
Climb Bio to Present at Upcoming Investor Conferences - GlobeNewswire
Nasdaq Futures Climb on Upbeat Alphabet Results, U.S. GDP Data and More Big Tech Earnings on Tap - MSN
Humic Acid Market Set to Climb to USD 1.63 Billion by 2030 - openPR
ABVC BioPharma receives $50,000 in incremental licensing fees, shares climb - MSN
Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph
Interpublic Group Of Cos., Inc. (IPG): Worth A Small Bite At $32.03 - Stocks Register
Why Lamb Weston Stock Was Climbing Today - Yahoo Finance
Big Bank Stocks Climb. 3 Stocks to Consider Adding to Your Portfolio. - Yahoo Finance
Treasury Yields Climb as Strong Data Sow Doubt on Fed Rate Cuts - Yahoo Finance
Mortgage Demand Sees Sharpest Weekly Drop Since April 2020 As Rates Climb Above 6.5% - Yahoo Finance
Korean growth stocks climb after rate cut - 코리아타임스
Vale Achieves Six-Year High in Iron Ore Output, Copper and Nickel Production Also Climb - Yahoo Finance
European Wax Center Continues to Climb in Franchise Times' Top 400 Ranking - Yahoo Finance
US Mortgage Rates Climb to 6.52%, Highest Since Early August - Yahoo Finance
What You Need to Know Ahead of Bio-Techne's Earnings Release - TradingView
Stocks of B. Riley Financial Inc (RILY) are poised to climb above their peers - SETE News
Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event - The Manila Times
‘Retirement super pot’ holders pay themselves around £3m each in a year - Yahoo Finance UK
Climb Bio to present kidney disease treatment study By Investing.com - Investing.com Australia
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024 - GlobeNewswire
Climb Bio to present kidney disease treatment study - Investing.com India
Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology - The Bakersfield Californian
A stock that deserves closer examination: Climb Bio Inc. (CLYM) - US Post News
Climb Global (CLMB) Surged on Strong Results - Yahoo Finance
Quarterly IPOs Climb Back Above $1bn - Scrip
US 30-Year Mortgage Rate Climbs by Most in More Than a Year - Yahoo Finance
Climb Global (CLMB) Moves 7.0% Higher: Will This Strength Last? - Yahoo Finance
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% - Baystreet.ca
Climb Bio to Present at William Blair’s Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - ForexTV.com
Climb Bio to Present at William Blair’s Upcoming Conference - GlobeNewswire
Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - The Manila Times
Intumescent Coatings Market Size to Climb to USD 2.4 - GlobeNewswire
Intumescent Coatings Market Size to Climb to USD 2.4 billion by 2034 with a 7.4% CAGR, Supported by Steel Fabrication Fireproofing Demand | States Transparency Market Research, Inc. - Yahoo Finance
First Merchants Corporation to Report Third Quarter 2024 Financial Results, Host Conference Call and Webcast - The Manila Times
Climb Bio to Host Virtual Investor Event on October 15, 2024 - GlobeNewswire
Eliem Therapeutics rebrands to Climb Bio, shifts focus to immune diseases By Investing.com - Investing.com South Africa
Eliem Therapeutics rebrands to Climb Bio, shifts focus to immune diseases - Investing.com
Eliem Therapeutics Changes Name to Climb Bio - Yahoo Finance
Eliem Therapeutics to change corporate name to Climb Bio - TipRanks
Techmer PM Expands Portfolio with Acquisition of OptiColor Inc. - The Manila Times
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc. - The Bakersfield Californian
Cisco Set For Technical Breakout As Golden Cross Signals Strength: Analyst Predicts Stock Will 'Quietly' Climb Higher - Yahoo Finance
Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up - Simply Wall St
Home sales climb with lower mortgage rates - Yahoo Finance
China’s Biggest Stock Buying Frenzy in Years Overwhelms Exchange - Yahoo Finance
Biomea stock jumps 9% after FDA lifts hold on Phase 1/2 study (update) - MSN
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
The price of gold keeps climbing to unprecedented heights. Here's why - Yahoo Finance
Equities, commodities climb after China announces stimulus - Yahoo Finance
Eliem Therapeutics: Recent Strategic Pipeline Restructuring (NASDAQ:ELYM) - Seeking Alpha
Oil prices climb on hurricane impact ahead of US rate decision - Yahoo Finance
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - The Motley Fool
INmune Bio stock dips on $13M securities offering - MSN
Biotech IPO Shares Climb in Debuts After Deals Upsized - Bloomberg
Dell shares climb on S&P 500 inclusion, analysts see more upside ahead - Proactive Investors Australia
Intelligent Bio Solutions stock rallies on reporting Q4 revenue of $0.73M, up 64% Y/Y - MSN
Dell shares climb on S&P 500 inclusion, analysts see more upside ahead By Proactive Investors - Investing.com Canada
1.11%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):